1 – 10 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial
- 2016
- Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity
- Cost evaluations of radiotherapy: what do we know? : an ESTRO-HERO analysis
- PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer
- How many new cancer patients in Europe will require radiotherapy by 2025? : an ESTRO-HERO analysis
- 2015
- Automated planning for lung SBRT: faster optimization without compromise on plan quality
- The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project
- Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer
- Deep inspiration breath hold in the prone position retracts the heart from the breast and internal mammary lymph node region
- New delineation guidelines for the elective lymph node regions in breast cancer radiation therapy